KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 117 filers reported holding KYMERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $207 | -22.5% | 9,014 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $267 | +18.7% | 9,014 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $225 | -99.9% | 9,014 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $381,000 | -33.4% | 9,014 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $572,000 | +8.1% | 9,014 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $529,000 | +19.7% | 9,014 | -1.1% | 0.00% | +50.0% |
| Q2 2021 | $442,000 | +26.3% | 9,114 | +1.1% | 0.00% | 0.0% |
| Q1 2021 | $350,000 | -37.4% | 9,014 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $559,000 | – | 9,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |